Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
Guardado en:
Autores principales: | Yutao Guo, Gregory YH Lip |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c78330bf52644c1af6a57bec8ba34dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rhythm Control in AF: Have We Reached the Last Frontier?
por: Gheorghe-Andrei Dan
Publicado: (2019) -
The Evolving Role of Catheter Ablation in Patients With Heart Failure and AF
por: Sandeep Prabhu, et al.
Publicado: (2019) -
Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings
por: Johan Ärnlöv, et al.
Publicado: (2021) -
Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)
por: David Ferreira, et al.
Publicado: (2021) -
Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: F Dastan
Publicado: (2020)